MedTrace Logo

Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face

NCT06745999 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-24

No results posted yet for this study

Summary

40 patients randomized 1:1 to receive cryotherapy followed by 10% ALA gel Red light PDT vs. to 10% ALA gel Red Light PDT followed by cryotherapy.

Conditions

  • Actinic Keratoses

Interventions

DRUG

Ameluz 10% Topical Gel

Paired with device intervention of red light PDT

DEVICE

Red Light PDT

Paired with drug intervention of Ameluz 10% topical gel

PROCEDURE

Cryotherapy

Liquid Nitrogen

Sponsors & Collaborators

  • Biofrontera Bioscience GmbH

    collaborator INDUSTRY

  • Psoriasis Treatment Center of Central New Jersey

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-03
Primary Completion
2025-05-31
Completion
2025-06-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745999 on ClinicalTrials.gov